Altman Z-Score
4.06
-0.68-14.35%
2 min ago
Summary
- As of February 25, 2025, RXRX Altman Z-Score is 4.06, with the most recent change of -0.68 (-14.35%) on February 25, 2025.
- RXRX current Altman Z-Score indicates the stock has a low bankruptcy risk.
Performance
RXRX Altman Z-Score Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Altman Z-Score Formula
Z-Score = 1.2*A + 1.4*B + 3.3*C + 0.6*D + 1.0*E- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
RXRX Altman Z-Score Trends
| PeriodPeriod | Altman Z-ScoreAltman Z-Score | PricePrice | Market capMarket cap |
|---|---|---|---|
| todaytoday | -14.3% | -8.7% | -8.7% |
| 1 m1 month | +15.7% | +8.2% | +8.2% |
| 3 m3 months | +78.1% | +32.7% | +32.7% |
| 6 m6 months | +5.7% | +1.5% | +3.1% |
| ytdytd | +35.3% | +17.2% | +17.2% |
| 1 y1 year | -39.6% | -40.3% | -27.1% |
| 5 y5 years | - | - | - |
Recursion Pharmaceuticals Altman Z-Score History
| Date | Value |
|---|---|
| 2025 | 4.06(+35.3%) |
| 2024 | 3.00(-29.1%) |
| Date | Value |
|---|---|
| 2023 | 4.23(+72.7%) |
| 2022 | 2.45(-90.2%) |
| 2021 | 25.03 |
FAQ
- What is Recursion Pharmaceuticals altman z-score?
- What is RXRX altman z-score year-to-date change?
- What is Recursion Pharmaceuticals altman z-score year-on-year change?
What is Recursion Pharmaceuticals altman z-score?
The current altman z-score of RXRX is 4.06
What is RXRX altman z-score year-to-date change?
Recursion Pharmaceuticals altman z-score has changed by +1.06 (+35.33%) since the beginning of the year
What is Recursion Pharmaceuticals altman z-score year-on-year change?
Over the past year, RXRX altman z-score has changed by -2.66 (-39.58%)